Keyes Stange & Wooten Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,132
Closed -$640K 74
2025
Q1
$640K Sell
7,132
-29
-0.4% -$2.71K 0.36% 35
2024
Q4
$712K Sell
7,161
-573
-7% -$59.1K 0.42% 28
2024
Q3
$878K Buy
7,734
+292
+4% +$34.7K 0.52% 22
2024
Q2
$921K Sell
7,442
-316
-4% -$40.7K 0.64% 22
2024
Q1
$1.02M Sell
7,758
-187
-2% -$23K 0.9% 18
2023
Q4
$866K Buy
+7,945
New +$825K 0.92% 19

Other funds holding MRK

Keyes Stange & Wooten Wealth Management's MRK Position: Q2 2025 in Review

Keyes Stange & Wooten Wealth Management sold out of Merck (MRK) in Q2 2025, closing a stake of 7,132 shares — an estimated $640K sold.

Keyes Stange & Wooten Wealth Management first reported a position in MRK in Q4 2023 and held it in 6 quarters. The position peaked at $1.02M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Keyes Stange & Wooten Wealth Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Keyes Stange & Wooten Wealth Management sold 7,132 Merck shares in Q2 2025, an estimated $640K.
  • Keyes Stange & Wooten Wealth Management first reported a position in Merck in Q4 2023 and held it in 6 quarters.
  • Keyes Stange & Wooten Wealth Management's Merck position peaked at $1.02M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Keyes Stange & Wooten Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.